Series C · HealthtechNeurent Medical: Series CDevelops NEUROMARK, a minimally invasive solution to treat chronic rhinitisPublished Oct 4, 2026By RoundOS Funding deskFunding historyFeb 11, 2026Series C · This round€62.5MSourcesprnewswire.com↗
WyLWyL provides home nursing, personal care and medically supported housing in Japan.~¥1.5BUndisclosed · Nov 18, 2026
PulmoGatePulmoGate develops remote specialist review and medical AI tools for interstitial lung disease.~¥330MSeed · Nov 18, 2026
NovAccelDevelops compact superconducting accelerators to produce medical radioisotopes.~¥290MPost-seed extension · Nov 17, 2026
Marrow TherapeuticsMarrow Therapeutics develops bone marrow-targeted genetic medicines for severe blood disorders.$120MSeries B · Nov 17, 2026